Gepner Adam D, Haller Irina V, Krueger Diane C, Korcarz Claudia E, Binkley Neil, Stein James H
University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Essentia Institute of Rural Health, Duluth, MN, USA.
Atherosclerosis. 2015 Jun;240(2):526-8. doi: 10.1016/j.atherosclerosis.2015.04.795. Epub 2015 Apr 25.
It is unclear if vitamin D supplementation improves central blood pressure or arterial stiffness in Native American (NA) women.
Healthy postmenopausal NA women were randomized to receive 400 IU or 2500 IU of vitamin D for 6 months. Central systolic blood pressure (cSBP), central pulse pressure (cPP) and aortic augmentation index (AIx) were estimated by tonometry at baseline and after 6 months.
Study volunteers (n = 98) were 61 (7.3) years old. 25(OH)D was 26.4 (11.0) ng/mL. 25(OH)D was similar between the two treatment groups (p = 0.291), as were baseline cSBP, cPP, and CVD risk factors (all p > 0.1). Treatment with 2500 IU of daily vitamin D3 did not affect cSBP, cPP, or AIx (all p > 0.1) compared to 400 IU daily.
Despite low serum 25(OH)D at baseline, 6 months of vitamin D supplementation did not improve central blood pressure parameters or arterial stiffness in NA women. CLINICAL TRIALS.
NCT01490333.
尚不清楚补充维生素D是否能改善美国原住民(NA)女性的中心血压或动脉僵硬度。
将健康的绝经后NA女性随机分为两组,分别接受400 IU或2500 IU维生素D治疗6个月。在基线和6个月后通过眼压测量法估算中心收缩压(cSBP)、中心脉压(cPP)和主动脉增强指数(AIx)。
研究志愿者(n = 98)年龄为61(7.3)岁。25(OH)D为26.4(11.0)ng/mL。两个治疗组之间的25(OH)D相似(p = 0.291),基线cSBP、cPP和心血管疾病风险因素也相似(所有p>0.1)。与每日400 IU相比,每日2500 IU维生素D3治疗对cSBP、cPP或AIx均无影响(所有p>0.1)。
尽管基线时血清25(OH)D水平较低,但补充6个月维生素D并未改善NA女性的中心血压参数或动脉僵硬度。临床试验。
NCT01490333。